Dr. David S. Lim
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 94
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
VA license 0101232451 -
Pediatrics Physician
VA license 0101232451
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 94
- Services billed
- 270
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Telephone medical discussion with physician, 11-20 minutes | 91 | 64 |
| Established patient office or other outpatient visit, 40-54 minutes | 47 | 44 |
| New patient office or other outpatient visit, 60-74 minutes | 43 | 43 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 21 | 21 |
| Repair of mitral valve through the skin, initial prosthesis | 20 | 20 |
| Repair of mitral valve through the skin, additional prosthesis | 15 | 15 |
| Replacement of aortic valve through the skin and femoral artery | 15 | 15 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 14 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Farxiga (dapagliflozin propanediol) Other prescribers in Charlottesville, VA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 53 payments worth $38,880 in total to this clinician.
| Medtronic, Inc. | $15,884 |
|---|---|
| W. L. Gore & Associates, Inc. | $13,908 |
| Biosense Webster, Inc. | $5,672 |
| Edwards Lifesciences Corporation | $3,400 |
| Abbott Laboratories | $15.62 |
| Consulting Fee | $19,730 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $13,152 |
| Travel and Lodging | $5,095 |
| Food and Beverage | $903 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. May 9, 2025 | Consulting Fee Product in Development · Devices | $6,240 |
| Medtronic, Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,569 |
| W. L. Gore & Associates, Inc. May 9, 2025 | Consulting Fee Product in Development · Devices | $4,680 |
| Medtronic, Inc. Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,400 |
| Biosense Webster, Inc. Jan 27, 2025 | Consulting Fee CARTO 3 · Cardiology | $3,200 |
| Biosense Webster, Inc. Jul 25, 2025 | Consulting Fee CARTO 3 · Cardiology | $2,400 |
| Medtronic, Inc. Feb 14, 2025 | Travel and Lodging travel to Vancouver, BC, Canada · in-kind | $2,167 |
| Medtronic, Inc. Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $1,623 |
| Edwards Lifesciences Corporation Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) SAPIEN 3 Ultra RESILIA · Transcatheter Heart Valves · in-kind | $1,169 |
| W. L. Gore & Associates, Inc. Dec 24, 2025 | Consulting Fee Product in Development · Devices | $780 |
All 27 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. Dec 24, 2025 | Consulting Fee Product in Development · Devices | $780 |
| W. L. Gore & Associates, Inc. Dec 24, 2025 | Consulting Fee Product in Development · Devices | $780 |
| Medtronic, Inc. Dec 15, 2025 | Consulting Fee | $550 |
| Edwards Lifesciences Corporation Nov 27, 2025 | Compensation for services other than consulting (speaking, faculty) EVOQUE · Transcatheter Valve Repair · in-kind | $392 |
| Medtronic, Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,569 |
| Medtronic, Inc. Sep 24, 2025 | Consulting Fee | $550 |
| Medtronic, Inc. Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $1,623 |
| Biosense Webster, Inc. Jul 25, 2025 | Consulting Fee CARTO 3 · Cardiology | $2,400 |
| Edwards Lifesciences Corporation Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) SAPIEN 3 Ultra RESILIA · Transcatheter Heart Valves · in-kind | $1,169 |
| Edwards Lifesciences Corporation Jul 10, 2025 | Travel and Lodging SAPIEN 3 Ultra RESILIA · Transcatheter Heart Valves · travel to Toronto, Canada | $67.91 |
| Edwards Lifesciences Corporation May 30, 2025 | Travel and Lodging travel to Toronto, Canada · in-kind | $360 |
| Edwards Lifesciences Corporation May 15, 2025 | Travel and Lodging travel to Toronto, Canada · in-kind | $516 |
| Edwards Lifesciences Corporation May 15, 2025 | Travel and Lodging travel to Toronto, Canada · in-kind | $319 |
| W. L. Gore & Associates, Inc. May 9, 2025 | Consulting Fee Product in Development · Devices | $6,240 |
| W. L. Gore & Associates, Inc. May 9, 2025 | Consulting Fee Product in Development · Devices | $4,680 |
| W. L. Gore & Associates, Inc. May 9, 2025 | Travel and Lodging Product in Development · Devices · travel to Phoenix, AZ · in-kind | $84.00 |
| W. L. Gore & Associates, Inc. May 9, 2025 | Travel and Lodging Product in Development · Devices · travel to Phoenix, AZ · in-kind | $35.60 |
| Medtronic, Inc. May 7, 2025 | Consulting Fee | $550 |
| W. L. Gore & Associates, Inc. Apr 25, 2025 | Travel and Lodging Product in Development · Devices · travel to Phoenix, AZ · in-kind | $45.04 |
| Medtronic, Inc. Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,400 |
| W. L. Gore & Associates, Inc. Apr 24, 2025 | Travel and Lodging Product in Development · Devices · travel to Phoenix, AZ · in-kind | $68.75 |
| W. L. Gore & Associates, Inc. Apr 23, 2025 | Travel and Lodging Product in Development · Devices · travel to Phoenix, AZ · in-kind | $127 |
| W. L. Gore & Associates, Inc. Apr 10, 2025 | Travel and Lodging GORE CARDIOFORM Septal Occluder · Devices · travel to Phoenix, AZ · in-kind | $679 |
| W. L. Gore & Associates, Inc. Apr 10, 2025 | Travel and Lodging GORE CARDIOFORM Septal Occluder · Devices · travel to Phoenix, AZ · in-kind | $261 |
| Medtronic, Inc. Feb 14, 2025 | Travel and Lodging travel to Vancouver, BC, Canada · in-kind | $2,167 |
| Medtronic, Inc. Feb 14, 2025 | Travel and Lodging travel to Vancouver, BC, Canada · in-kind | $363 |
| Biosense Webster, Inc. Jan 27, 2025 | Consulting Fee CARTO 3 · Cardiology | $3,200 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 2 companies. The companies reported $105,779 in research payments for these studies, mostly to the institutions running them.
- CLASP IIF (2018-07)
Edwards Lifesciences Corporation - CLASP IID 2018-07
Edwards Lifesciences Corporation - Edwards PASCAL Transcatheter Valve Repair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards Lifesciences Corporation - The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study (2016-05)
Edwards Lifesciences Corporation - NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.